Results 81 to 90 of about 13,250 (212)
Acute Effects of Albuterol on Ventilatory Capacity in Children with Asthma
Background: Children with asthma may have a reduced ventilatory capacity, which could lead to symptoms and early termination of a cardiopulmonary exercise test (CPET).
Michael W. H. Wong +2 more
doaj +1 more source
Albuterol as an adjunctive treatment to enzyme replacement therapy in infantile-onset Pompe disease
Background: Early initiation of enzyme replacement therapy (ERT) with recombinant human acid alpha-glucosidase is an effective treatment for patients with infantile-onset Pompe disease (IOPD) but cannot prevent a slow progression of myopathy.
Yin-Hsiu Chien +7 more
doaj +1 more source
IntroductionBoth in vitro and in vivo radiolabelled studies on nebulisation via high-flow nasal cannula showed that inhaled dose decreases as the administered gas flow increases. In our previous in vitro study, we investigated the effects of the ratio of
Jian Luo +3 more
doaj +1 more source
Inhibition of cholinesterases by albuterol carbamate [PDF]
OdreĎene su konstante brzine inhibicije dviju butirilkolinesteraza (BChE; EC 3.1.1.8) i dviju acetilkolinesteraza (AChE; EC 3.1.1.7) s racemičnim, (R)- i (S)- N,N-dimetilkarbamatom albuterola (4-(2-(tert-butilamino)-1-hidroksietil)-2-(hidroksimetil ...
Kerep, Robert
core
The beta(2)-adrenergic agonist, albuterol, is used as a bronchodilator by patients with asthma and consists of a racemic mixture of (R)- and (S)-albuterol. However, the action of the individual enantiomers is poorly understood.
Delmotte, Philippe +1 more
core +1 more source
Introduction: Salbutamol is a moderately selective beta-2-adrenergic agonist. Various side effects can occur because of beta-1 and beta-2 receptor activation. Due to the large volume of distribution, it is not considered dialyzable.
Neva Bezeljak +3 more
doaj +1 more source
Objectives: Continuous nebulized albuterol is frequently used to treat children with status asthmaticus in the pediatric intensive care unit (PICU) but can have cardiovascular side effects. Limited data exist comparing different dosages.
Ada T. Lin (6830912) +2 more
core +1 more source
David B Price,1,2 Anna Rigazio,2 Mary Buatti Small,3 Thomas J Ferro,3 1Academic Primary Care, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK; 2Research in Real-Life Ltd, Cambridge, UK; 3Teva Pharmaceuticals, Frazer, PA, USA ...
Price DB +3 more
doaj
Background: Long-acting bronchodilators are preferred over short-acting bronchodilators in patients with stable COPD, but prospective studies are needed to determine the safety and efficacy of nebulized long-acting bronchodilators in hospitalized ...
Rajiv Dhand, MD +15 more
doaj +1 more source
A reversibility test by an increase of greater than 12% in FEV1 can support a diagnosis of asthma and alter a patient’s treatment plan but may not be applicable to the young ages.
Daphna Vilozni +5 more
doaj +1 more source

